{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:47:37Z","timestamp":1771627657486,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA206180"],"award-info":[{"award-number":["R01 CA206180"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.aohep.2024.101529","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:15:45Z","timestamp":1721438145000},"page":"101529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases"],"prefix":"10.1016","volume":"29","author":[{"given":"Kamyar","family":"Ghabili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin-Marley","family":"Windham-Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menelaos","family":"Konstantinidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikitha","family":"Murali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabea","family":"Borde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9067-1710","authenticated-orcid":false,"given":"Lucas C.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-9793","authenticated-orcid":false,"given":"Fabian","family":"Laage-Gaupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MingDe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Georgiades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariman","family":"Nezami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aohep.2024.101529_bib0001","first-page":"1477","article-title":"Incidence and prognosis of liver metastasis at diagnosis: a pan-cancer population-based study","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"2","key":"10.1016\/j.aohep.2024.101529_bib0002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0040-1712146","article-title":"Embolotherapy for hepatic oncology: current perspectives and future directions","volume":"4","author":"Bajwa","year":"2020","journal-title":"Dig Dis Interv"},{"issue":"2","key":"10.1016\/j.aohep.2024.101529_bib0003","first-page":"108","article-title":"Locoregional liver-directed therapies to treat unresectable colorectal liver metastases: a review","volume":"36","author":"McFadden","year":"2022","journal-title":"Oncology (Williston Park)"},{"issue":"1052","key":"10.1016\/j.aohep.2024.101529_bib0004","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140564","article-title":"Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions","volume":"88","author":"Duran","year":"2015","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101529_bib0005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0040-1719189","article-title":"Interventional oncology approach to hepatic metastases","volume":"37","author":"O'Leary","year":"2020","journal-title":"Semin Intervent Radiol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101529_bib0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/1754-9485.12163","article-title":"Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature","volume":"58","author":"Bester","year":"2014","journal-title":"J Med Imag Radiat Oncol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101529_bib0007","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiol.2021204248","article-title":"If at first you Don't succeed, TACE and TACE again","volume":"298","author":"Georgiades","year":"2021","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.aohep.2024.101529_bib0008","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1148\/radiol.2021202289","article-title":"Lack of response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: abandon or repeat?","volume":"298","author":"Chen","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101529_bib0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1148\/radiol.12112264","article-title":"Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?","volume":"265","author":"Georgiades","year":"2012","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101529_bib0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jhep.2015.01.022","article-title":"Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma","volume":"62","author":"Kim","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101529_bib0011","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2012.07.025","article-title":"Response rate and clinical outcome of HCC after first and repeated cTACE performed \"on demand\"","volume":"57","author":"Terzi","year":"2012","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2024.101529_bib0012","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/hpb.12313","article-title":"Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma","volume":"16","author":"White","year":"2014","journal-title":"HPB (Oxford)"},{"issue":"21","key":"10.1016\/j.aohep.2024.101529_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215366","article-title":"Long term efficacy and assessment of tumor response of transarterial chemoembolization in neuroendocrine liver metastases: a 15-year monocentric experience","volume":"13","author":"Touloupas","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.aohep.2024.101529_bib0014","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s11605-007-0235-7","article-title":"Repeat transarterial chemoembolization (TACE) for progressive hepatic carcinoid metastases provides results similar to first TACE","volume":"11","author":"Varker","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.aohep.2024.101529_bib0015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.clinimag.2021.05.007","article-title":"Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: post-hoc analysis of a prospective clinical trial","volume":"78","author":"Letzen","year":"2021","journal-title":"Clin Imaging"},{"key":"10.1016\/j.aohep.2024.101529_bib0016","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinimag.2022.06.013","article-title":"Response assessment methods for patients with hepatic metastasis from rare tumor primaries undergoing transarterial chemoembolization","volume":"89","author":"Adam","year":"2022","journal-title":"Clin Imaging"},{"issue":"1","key":"10.1016\/j.aohep.2024.101529_bib0017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00330-015-3812-2","article-title":"Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement","volume":"26","author":"Chockalingam","year":"2016","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101529_bib0018","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejrad.2013.11.016","article-title":"Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma","volume":"83","author":"Bonekamp","year":"2014","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101529_bib0019","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1148\/radiol.14140033","article-title":"Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis","volume":"273","author":"Chapiro","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101529_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.2015142951","article-title":"Comparison of existing response criteria in patients with hepatocellular carcinoma treated with transarterial chemoembolization using a 3D quantitative approach","volume":"278","author":"Tacher","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101529_bib0021","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2024.101529_bib0022","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1007\/s00330-021-08058-7","article-title":"Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy","volume":"31","author":"Ghani","year":"2021","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.aohep.2024.101529_bib0023","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00270-022-03209-9","article-title":"Analysis of tumor burden as a biomarker for patient survival with neuroendocrine tumor liver metastases undergoing intra-arterial therapies: a single-center retrospective analysis","volume":"45","author":"Miszczuk","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101529_bib0024","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejrad.2014.11.034","article-title":"Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival","volume":"84","author":"Chapiro","year":"2015","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.aohep.2024.101529_bib0025","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00330-015-3595-5","article-title":"Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver","volume":"25","author":"Chapiro","year":"2015","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101529_bib0026","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tranon.2014.05.004","article-title":"Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization","volume":"7","author":"Duran","year":"2014","journal-title":"Transl Oncol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101529_bib0027","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1148\/radiol.2016160838","article-title":"Imaging biomarkers of tumor response in neuroendocrine liver metastases treated with transarterial chemoembolization: can enhancing tumor burden of the whole liver help predict patient survival?","volume":"283","author":"Sahu","year":"2017","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101529_bib0028","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/14737140.2015.978861","article-title":"Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI","volume":"15","author":"Chapiro","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"12","key":"10.1016\/j.aohep.2024.101529_bib0029","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jvir.2012.08.028","volume":"23","author":"Lin","year":"2012","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101529_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.212426","article-title":"Optimization of the BCLC staging system for locoregional therapy for hepatocellular carcinoma by using quantitative tumor burden imaging biomarkers at MRI","volume":"304","author":"Borde","year":"2022","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.aohep.2024.101529_bib0031","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tranon.2016.03.005","article-title":"Hypo-vascular liver metastases treated with transarterial chemoembolization: assessment of early response by volumetric contrast-enhanced and diffusion-weighted magnetic resonance imaging","volume":"9","author":"Sobhani","year":"2016","journal-title":"Transl Oncol"},{"issue":"10","key":"10.1016\/j.aohep.2024.101529_bib0032","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S1470-2045(22)00506-X","article-title":"Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis","volume":"23","author":"Ecker","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T21:18:51Z","timestamp":1731187131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1665268124003235"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101529","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101529"}}